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Desminopathies are rare inherited diseases caused by
mutations in the desmin gene. Diagnosis of desminopathies
is challenging because of their low incidence and the broad
spectrum of clinical presentations. The present report (1)
describes a new clinical presentation mimicking recurrent
myocarditis, extending the clinical phenotype associated
with desmin mutations; and (2) demonstrates that the
Purkinje system is involved in the pathogenesis of conduc-
tion disturbances related to desminopathies.Case report
We report the case of a 50-year-old woman with an unusual
cardiac phenotype related to a dominant mutation in the desmin
gene. The patient did not have any signiﬁcant medical history
except asthma during childhood. There was no family history of
cardiomyopathies, sudden death, or cardiac device implantation.
She was ﬁrst admitted to our hospital for an episode of chest pain
radiating to her jaw and down her left arm. Her physical
examination was strictly normal. Electrocardiogram at admission
revealed a ﬁrst-degree atrioventricular block associated with
nonspeciﬁc intraventricular conduction disturbances (Figure 1A).
A second electrocardiogram exhibited an episode of alternating
bundle branch block (Figure 1B). Laboratory investigations
showed elevated troponin T (84 ng/l; normal o50 ng/l) and
creatine kinase (397 UI/l; normalo200 UI/l). C-reactive protein
was normal (4 mg/l; normalo6 mg/l). The echocardiogram was
normal (left ventricular ejection fraction ¼ 60%), as well as theKEYWORDS Desminopathy; Myocarditis; Cardiomyopathy; Atrioventricular
block; Pacemaker; Desmin; Purkinje
ABBREVIATIONS EPS ¼ electrophysiologic study; ICD ¼ implantable
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The diagnosis of myocarditis was suspected and symptoms
spontaneously resolved within 12 hours. Given the unusual
electrocardiographic features, an electrophysiologic study (EPS)
was performed, revealing advanced His-Purkinje system disease
(Figure 1C and D). No programmed ventricular stimulation was
performed during the EPS. A dual-chamber pacemaker was
therefore implanted immediately. The patient was readmitted 3
months later for a recurrence of a retrosternal chest pain
associated with an increase in troponin T level (75 ng/l). Cardiac
magnetic resonance revealed a large area of subepicardial late
gadolinium enhancement located in the lateral wall of the left
ventricle (Figure 2). A deltoid muscle biopsy was performed, and
histopathologic ﬁndings revealed features of myoﬁbrillar myo-
pathy with desmin-positive protein aggregates (Figure 3).
Genetic molecular analysis revealed a heterozygous missense
mutation (c.38C4T; p.Ser13Phe) in the desmin gene (GenBank
accession number NM001927.3) (Supplementary Figure, avail-
able online). The variant fulﬁlled all the criteria for a disease-
causing mutation. Additionally, this mutation was already
published as pathogenic1–3 and is located in the head domain
of the protein. No mutation was identiﬁed in the lamin A/C
gene. Following these results, the pacemaker was upgraded
to an implantable cardioverter-deﬁbrillator (ICD); genetic screen-
ing of relatives is ongoing. After 24 months of follow-up, no
recurrence of chest pain occurred and echocardiograms remain
normal, without evidence for structural cardiomyopathy on
echocardiography.
Discussion
Desminopathies are rare diseases related to mutations in the
desmin gene located on chromosome 2q35. The spectrum of
clinical presentations is broad, including variable association
of progressive skeletal muscle weakness and cardiac
involvement. Cardiac manifestations are mostly represented
by cardiomyopathies (the most frequent being dilated andpen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2015.04.002
KEY TEACHING POINTS
 Desminopathies are rare genetic diseases caused by
mutations in the desmin gene located on chromosome
2q35. The spectrum of clinical presentations is broad,
including variable associations of progressive skeletal
muscle weakness and cardiac involvement.
 The present report describes a new clinical
presentation characterized by an isolated cardiac
phenotype mimicking recurrent myocarditis
combined with conduction disturbances, thereby
extending the clinical phenotype associated with
desmin gene mutations.
 This report provides evidence of the involvement of
the Purkinje system in the pathogenesis of
conduction disturbances related to desminopathies.
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The present report highlights remarkable features related to a
desmin gene mutation (c.38C4T; p.Ser13Phe).
First of all, the cardiac presentation fulﬁlled criteria for
suspected acute myocarditis.6 This cardiac phenotype ofFigure 1 A: Baseline 12-lead electrocardiogram (25 mm/s, 10 mm/mV) showing
a nonspeciﬁc intraventricular conduction disturbance (QRS duration ¼ 150 ms w
deviation (701). B: Second electrocardiogram showing conduction disturbances.
aberration in the form of left bundle branch block. Thus, this beat shows a left bun
following beats show a right bundle branch block pattern with shorter PR interval
mV). Two quadripolar catheters were used: the ﬁrst one was positioned on the tric
“HIS m,” and “His d”); the second one was positioned on the right atrium free wall
o55 ms) was noted. D: Pharmacologic challenge (ajmaline infusion, 1 mg/kg) ind
ventricular electrogram after the hisian potential (asterisk). A, atrial electrogram. Hmyocarditis has not yet been reported in desminopathies, the
most frequent types of cardiomyopathies described in this
disease being dilated and restrictive cardiomyopathies. Even
if the causal relationship between gene mutation and
myocarditis cannot be stated with certainty, this unusual
presentation revealing the disease might represent an early
stage of the pathologic process and questions the possible
interrelations between myocarditis and genetic cardiomyo-
pathies (as observed in arrhythmogenic right ventricular
cardiomyopathy or dilated cardiomyopathy). It also high-
lights the possibility of overlapping between clinical pheno-
types induced by desmin mutations, as has been reported for
mutations in other genes.7,8 This clinical presentation of
“pseudo-myocarditis” has already been reported in other
genetic cardiomyopathies, such as arrhythmogenic right
ventricular cardiomyopathy.9,10 Acute myocarditis may
reﬂect an “active phase” of the underlying genetic cardiomy-
opathy and may play a role in the acceleration of myocardial
involvement.11,12 This suggests complex interactions
between genetic and environmental factors for the produc-
tion of a given phenotype. Finally, the report illustrates the
quite late expression of a genetic disease.
Secondly, isolated cardiac signs revealed the disease, as
there was no skeletal muscle weakness. Isolated cardiaca ﬁrst-degree atrioventricular block (PR duration¼ 230 ms) combined with
ithout criteria for left or right bundle branch block) and a marked left-axis
The ﬁrst QRS beat (asterisk) is preceded by a premature atrial beat, causing
dle branch block pattern with prolonged PR interval (300 ms), whereas the 2
(240 ms). C, D: Results from electrophysiologic study (200 mm/s, 10 mm/
uspid annulus to record the His bundle electrogram (leads labeled “HIS p,”
(lead labeled “RA”). C: At baseline, a prolonged HV interval (65 ms; normal
uced a 2:1 second-degree infrahisian block, demonstrated by the absence of
, hisian electrogram. V, ventricular electrogram.
Figure 2 Cardiac magnetic resonance ﬁndings. T1-weighted late gadolinium images showing a large area of subepicardially distributed late gadolinium
enhancement of the lateral wall of the left ventricle (arrows). Note the nonischemic regional distribution of the lesion, which excludes the subendocardial layer.
There was no increased global myocardial early gadolinium enhancement ratio between myocardium and skeletal muscle in gadolinium-enhanced T1-weighted
images. Finally, no myocardial signal intensity increase was noted in T2-weighted edema images (images not shown). A: Four-chamber view. B: Short-
axis view.
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muscular weakness have less frequently been described in
carriers of desmin gene mutations. The location of the
mutation (head, helix domains, or tail) might inﬂuence the
phenotype. In the present case, the mutation (p.Ser13Phe)
was located in the head domain. A meta-analysis4 demon-
strated that mutations in the head or tail domain of the
desmin gene are both rarely observed and more likely toFigure 3 Histopathologic ﬁndings.A:Hematoxylin–eosin sections. Note the het
sarcoplasmic aggregates. Arrowheads indicate the centralization of nuclei. B: Gom
arrows indicate subsarcolemmal protein aggregates. C: Desmin immunostaining. A
Electron microscope ﬁndings showing granuloﬁlamentous material (asterisk).result in an isolated cardiac phenotype. In the present case,
the p.Ser13Phe mutation is located at a protein kinase-C
phosphorylation site within a highly conserved nonapeptide
sequence in the head domain of the desmin protein. It
was ﬁrst described by Bergman et al3 in 2007 in 2 Dutch
families presenting a phenotype varying from isolated
dilated cardiomyopathy to a generalized skeletal myopathy
with mild respiratory problems. Pica et al2 in 2008 publishederogeneity of the diameter of muscular ﬁbers. Arrows indicate the presence of
ori trichrome. Solid arrows indicate sarcoplasmic protein aggregates; dotted
rrows indicate desmin-positive protein aggregates within the sarcolemma. D:
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block associated with mild proximal and distal limb weak-
ness. In 2009, van Tintelen et al1 gave a precise description
of the clinical presentation of 27 patients from 5 families.
The p.Ser13Phe mutation was fully penetrant and respon-
sible for a cardiac involvement characterized by atrioven-
tricular block at young ages and right ventricular
involvement particularly in 2 patients who fulﬁlled the
diagnostic criteria for arrhythmogenic right ventricular
cardiomyopathy.
Thirdly, an EPS provided evidence that the con-
duction block was located below the atrioventricular node,
within the His-Purkinje system. If cardiac conduction disease
is recognized as one of the clinical manifestations of
desminopathies, there are no data in wider literature regard-
ing the precise location of conduction delays within the
conduction system. To the best of our knowledge, results of
electrophysiologic studies have not been reported yet in this
pathology. The present report demonstrates that electro-
cardiographic abnormalities are a result of an impairment
in infrahisian conduction, whereas atrioventricular nodal
conduction remains strictly normal. Of note, the conduction
disturbances persisted after resolution of myocarditis, this
ﬁnding strongly supporting a causal relationship between the
desmin mutation and the conduction disease. In an animal
model, Schrickel et al13 found slower conduction velocities
in the ventricles of desmin knockout mice, which is
consistent with the fact that desmin is a major component
of the Purkinje network. They did not observe any prolon-
gation of AH and HV intervals, but this animal model was
associated with a lower incidence of both atrioventricular
conduction disturbances and ventricular tachyarrhythmias
than what is observed in humans with heterozygous
mutations.
Finally, owing to the very low prevalence of desmino-
pathies, there is no consensus regarding indications for
prophylactic ICD implantation in this pathology. In patients
with severe conduction disturbances caused by LMNA
mutations, it is recognized that an ICD rather than a pace-
maker should be implanted, because these patients exhibit a
high risk of sudden death despite pacemaker implantation.14
In the present case, the decision to upgrade the pacemaker to
an ICD was based on previously published work5 reporting
the occurrence of ventricular tachyarrhythmias in 4 out of 28
carriers of DES mutations, as well as sudden death in 1 other
patient and in 6 out of 14 relatives who had pacemakers for
conduction disturbances. Even if it was not possible to draw
any signiﬁcant association between sudden death or ven-
tricular tachyarrhythmias and left ventricular function owing
to the limited number of patients, these data support the
prophylactic implantation of an ICD rather than a pacemaker
in patients presenting with severe conduction disturbances,
regardless of left ventricular function. This strategy of
prophylactic ICD implantation is also supported by another
publication15 reporting the case of a 24-year-old patient who
received a prophylactic ICD in the setting of DES mutation
with subnormal left ventricular ejection fraction (50%) andno inducible tachyarrhythmias during EPS. This patient
subsequently experienced an episode of fast ventricular
tachycardia terminated by shock, despite the absence of left
ventricular dysfunction. Finally, the presence of late gado-
linium enhancement might increase the risk of ventricular
tachyarrhythmias and has also been taken into account in our
decision to upgrade the pacemaker to an ICD.
Conclusion
In conclusion, this report (1) extends the spectrum of
phenotypes related to desmin mutations, and (2) provides
evidence that conduction disturbances are located within the
Purkinje system.
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